GAMMA Investing’s Alto Neuroscience ANRO Stock Holding History

GAMMA Investing’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.89K	Buy	270 +262	+3,275%	+$7.87K	﹤0.01%	3525
2026 Q2	$211	Buy	+8	New	+$185	﹤0.01%	4090

Other funds holding ANRO

Revisor Wealth Management Akron, Ohio $404M AUM 18.59% 1-Year Est. Return

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

GAMMA Investing's ANRO Position: Q3 2026 in Review

GAMMA Investing increased its Alto Neuroscience (ANRO) stake by 3,275% in Q3 2026, buying an estimated $7.87K and bringing the position to 270 shares worth $6.89K. The position accounts for ﹤0.01% of the portfolio, ranked #3525.

GAMMA Investing first reported a position in ANRO in Q2 2026 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.

GAMMA Investing held 270 shares of Alto Neuroscience worth $6.89K as of Q3 2026.
GAMMA Investing bought 262 Alto Neuroscience shares in Q3 2026, an estimated $7.87K.
Alto Neuroscience made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3525 holding.
GAMMA Investing first reported a position in Alto Neuroscience in Q2 2026 and has held it in 2 quarters since.
8 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.